Mesalamine and Reproductive Health Study
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Beth Israel Deaconess Medical Center
Related studies linked through entity extraction aliases.
Effectiveness of Open and Robotic Prostatectomy
- Status
- COMPLETED
- Phase
- N/A
Coenzyme Q10 in Post-Cardiac Arrest Cerebral Resuscitation
- Status
- COMPLETED
- Phase
- PHASE2
The VMVN Study: Virological Monitoring in Viet Nam
- Status
- COMPLETED
- Phase
- NA
Electronic Medical Record Reminders and Panel Management to Improve Primary Care of Elderly Patients
- Status
- COMPLETED
- Phase
- NA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: AEGIS CLIA
- Status
- COMPLETED
- Phase
- N/A
Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Supplemental Oxygen on Maximal Oxygen Consumption in Patients With Chronic Obstructive Pulmonary Disease
- Status
- COMPLETED
- Phase
- NA
Effect of Dietary Fat on Glycemic Control in Type 1 Diabetes
- Status
- COMPLETED
- Phase
- NA
IL-2 "SELECT" Tissue Collection Protocol in Patients With Advanced Melanoma
- Status
- COMPLETED
- Phase
- N/A
Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Panobinostat With Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
In Vivo Leptin Signaling in Humans After Acute Leptin Administration
- Status
- COMPLETED
- Phase
- PHASE1
Sleep Apnea Intervention for Cardiovascular Disease Reduction
- Status
- COMPLETED
- Phase
- NA
Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
MK-2206 for Recurrent Malignant Glioma
- Status
- WITHDRAWN
- Phase
- PHASE2
Effect on Acetaminophen Metabolism by Liquid Formulations
- Status
- COMPLETED
- Phase
- NA
Ofatumumab for Initial Systemic Treatment of Indolent B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trial of a Silver Eluting Dressing System
- Status
- COMPLETED
- Phase
- PHASE4